Patients with Alzheimer’s Disease showed normal FHL2 methylation, whereas in the blood of patients with Grave’s Disease a marked hypomethylation was found for one of the FHL2 CpG sites [90]. This evidence concerns the gene FHL2 and Alzheimer disease.